Ann: Application for quotation of securities - TTT, page-11

First 11 Last

Share
Profile

Follow
Hrunting

365 Posts.

113

08/05/23

12:31

Post #: 67656971
Share

Originally posted by Just a dash: ↑

Good morning Hrunting,

When I first invested in TTT in early 2017, I was extremely Bullish. I knew it was a disruptor with its technology and that is what appealed to me.

However, around September 2019 (from memory), I started getting Bad vibes. There were a few 'Red flag's going off in my head that was unwise to ignore. The majority of it stemmed from the former CEO Jeff Lang and the words, vagueness and certain phrases he would use. It was all wishy washy stuff. I do not have time to go through my posts from that era but around that time, I was highlighting my concerns to this very Forum with ample facts and data to back this up. It would still be all in there. The main concerns were the lack of revenue despite always being promised, deadlines forever being missed or then completely not spoken about again and contracts that would simply disappear into thin air......plus a few more.

Jeff Lang reminded me of another CEO from a public listed company from many moons ago who promised the world so much but could never back it up and had no accountability for his actions or statements. That particular company went into receivership and I, like you, stayed in for way too long when I should have cut my losses so much sooner. I lost a lot of money in that company.

I knew that TTT was going down the exact same path therefore I sold out of TTT making a slight loss in December 2020. I am so glad I did.

I did try to warn people with my own experiences. Some listened, some didn't. There were 2 posters in particular who for some reason (going by their 'Great analysis' hits) had a lot of sway on this forum. I knew these two investors were completely clueless with little idea therefore I would raise my concerns to all and sundry to try and balance the argument.

I wish you all the very best Hrunting with your investing! TTT is still on my watchlist therefore I like to review it every 3 months.

Expand

Thank you for your reply JaD. Yes... makes sense.

TTT was one of my first investments, so was asking from the point of view of having missed something along the way. Lesson for me is to curb my enthusiasm when seeing those types of videos and statements from a CEO. Couple that with my inexperience with the stock market at the time.

Anyway onwards and upwards. Same, will be watching TTT to see how it pans out.

Thank you! Likewise, all the best with your investments.

TTT Price at posting: 9.4¢ Sentiment: None Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

The iron ore comeback: Can it last?

ZNC

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

HAS

Hastings progressing Yangibana to production with lower costs

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 9 more messages in this thread...

First 11 Last

Add TTT (ASX) to my watchlist

(20min delay)
Last 13.0¢		Change 0.000(0.00%)		Mkt cap ! $134.1M

Open	High	Low	Value	Volume
13.0¢	13.5¢	12.5¢	$126.6K	973.9K

Buyers (Bids)

No.	Vol.	Price($)
8	747356	12.5¢

Sellers (Offers)

Price($)	Vol.	No.
13.0¢	137651	2

View Market Depth

No.	Vol.	Price($)
7	722356	0.125
7	835033	0.120
10	265041	0.115
15	955485	0.110
7	678477	0.105

Price($)	Vol.	No.
0.130	137651	2
0.135	428383	3
0.140	401859	6
0.145	205000	5
0.150	156334	5

Last trade - 16.10pm 30/09/2024 (20 minute delay)

TTT (ASX) Chart

Ann: Application for quotation of securities - TTT, page-11

The iron ore comeback: Can it last?

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Hastings progressing Yangibana to production with lower costs

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Application for quotation of securities - TTT, page-11

Top Stories

The iron ore comeback: Can it last?

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Hastings progressing Yangibana to production with lower costs

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News